Diabetes, Vol 48, Issue 5 1101-1107, Copyright © 1999 by American Diabetes Association

ARTICLES

Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart

A Virkamaki and H Yki-Jarvinen
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA. virkamaa@joslab.harvard.edu

Glucosamine infusion induces insulin resistance in vivo, but the effect of glucosamine on intracellular metabolites of the hexosamine pathway, especially glucosamine-6-phosphate (GlcN6P) is unknown. Because of the structural similarity of glucose-6-phosphate (G-6-P) and GlcN6P, we hypothesized that accumulation of this metabolite might alter the activities of enzymes such as glycogen synthase and hexokinase. We infused glucosamine (30 micromol x kg(-1) x min(-1)) to induce insulin resistance in rats during a euglycemic-hyperinsulinemic clamp. Glucosamine induced whole-body insulin resistance, which was apparent after 90 min and continued progressively for 360 min. Despite inducing severe whole-body insulin resistance and decrease in glycogen synthase fractional activity in rectus abdominis muscle (69+/-3 vs. 83+/-1%, P<0.01) and heart (7+/-1 vs. 32+/-4%, P<0.001), glucosamine did not change the glycogen content in rectus and even increased it in the heart (209+/-13 vs. 117+/-9 mmol/kg dry wt, P<0.001). Glucosamine increased tissue concentrations of UDP-GlcNAc 4.4- and 4.6-fold in rectus abdominis and heart, respectively. However, GlcN6P concentrations increased 500- and 700-fold in glucosamine-infused animals in rectus abdominis (590+/-80 vs. 1.2+/-0.1 micromol/kg wet wt, P<0.001) and heart (7,703+/-993 vs. 11.2+/-2.3 micromol/kg wet wt, P<0.001). To assess the possible significance of GlcN6P accumulation, we measured the effect of GlcN6P on glycogen synthase and hexokinase activity in vitro. At the GlcN6P concentrations measured in rectus abdominis and heart in vivo, glycogen synthase was activated by 21 and 542%, while similar concentrations inhibited hexokinase activity by 5 and 46%, respectively. This study demonstrates that infusion of glucosamine during a euglycemic-hyperinsulinemic clamp results in marked accumulation of intracellular GlcN6P. The GlcN6P concentrations in the heart and rectus abdominis muscle reach levels sufficient to cause allosteric activation of glycogen synthase and inhibition of hexokinase.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8. [Abstract] [Full Text] [PDF]

				S. Marshall, O. Nadeau, and K. Yamasaki Glucosamine-induced Activation of Glycogen Biosynthesis in Isolated Adipocytes: EVIDENCE FOR A RAPID ALLOSTERIC CONTROL MECHANISM WITHIN THE HEXOSAMINE BIOSYNTHESIS PATHWAY J. Biol. Chem., March 25, 2005; 280(12): 11018 - 11024. [Abstract] [Full Text] [PDF]

				M. W. Poustie, J. Carran, K. McEleney, S. J. Dixon, T. P. Anastassiades, and S. M. Bernier N-Butyryl Glucosamine Increases Matrix Gene Expression by Chondrocytes J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 610 - 616. [Abstract] [Full Text] [PDF]

				S. Marshall, O. Nadeau, and K. Yamasaki Dynamic Actions of Glucose and Glucosamine on Hexosamine Biosynthesis in Isolated Adipocytes: DIFFERENTIAL EFFECTS ON GLUCOSAMINE 6-PHOSPHATE, UDP-N-ACETYLGLUCOSAMINE, AND ATP LEVELS J. Biol. Chem., August 20, 2004; 279(34): 35313 - 35319. [Abstract] [Full Text] [PDF]

				K. Sakai and D. R. Clemmons Glucosamine Induces Resistance to Insulin-Like Growth Factor I (IGF-I) and Insulin in Hep G2 Cell Cultures: Biological Significance of IGF-I/Insulin Hybrid Receptors Endocrinology, June 1, 2003; 144(6): 2388 - 2395. [Abstract] [Full Text] [PDF]

				M. G. Buse, K. A. Robinson, B. A. Marshall, R. C. Hresko, and M. M. Mueckler Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E241 - E250. [Abstract] [Full Text] [PDF]

				A. R. Shikhman, K. Kuhn, N. Alaaeddine, and M. Lotz N-Acetylglucosamine Prevents IL-1{{beta}}-Mediated Activation of Human Chondrocytes J. Immunol., April 15, 2001; 166(8): 5155 - 5160. [Abstract] [Full Text] [PDF]

				D. M. Mott, C. Hoyt, R. Caspari, K. Stone, R. Pratley, and C. Bogardus Palmitate oxidation rate and action on glycogen synthase in myoblasts from insulin-resistant subjects Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E561 - E569. [Abstract] [Full Text] [PDF]

				M. J. Brady, P. M. Kartha, A. A. Aysola, and A. R. Saltiel The Role of Glucose Metabolites in the Activation and Translocation of Glycogen Synthase by Insulin in 3T3-L1 Adipocytes J. Biol. Chem., September 24, 1999; 274(39): 27497 - 27504. [Abstract] [Full Text] [PDF]

				B. A. Nelson, K. A. Robinson, and M. G. Buse Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E497 - E506. [Abstract] [Full Text] [PDF]